Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
94 studies found for:    "Oligoastrocytoma"
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved
Conditions: Oligodendroglioma;   Oligoastrocytoma
Intervention: Drug: Palbociclib
2 Completed Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
Conditions: Oligoastrocytoma, Mixed;   Anaplastic Oligodendroglioma
Intervention: Drug: Temozolomide
3 Completed Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial
Conditions: Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Drug: Temozolomide
4 Completed Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
Conditions: Astrocytoma;   Oligo-Astrocytoma;   Glioma
Intervention: Biological: GAA/TT-peptide vaccine and poly-ICLC
5 Active, not recruiting Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
6 Recruiting A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
Conditions: Glioblastoma Multiforme;   Anaplastic Oligoastrocytoma
Interventions: Biological: INXN-2001;   Drug: veledimex
7 Recruiting Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors
Conditions: Adult Anaplastic Oligodendroglioma;   Adult Mixed Glioma;   Adult Oligodendroglioma;   Oligoastrocytoma;   Recurrent Adult Brain Neoplasm
Interventions: Drug: Carboplatin;   Drug: Etoposide Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Mannitol;   Drug: Melphalan;   Other: Quality-of-Life Assessment;   Drug: Sodium Thiosulfate
8 Completed IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Oligoastrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: Surgery for placement;   Procedure: Radiation therapy;   Drug: Temozolomide with radiation therapy
9 Completed Neural Basis of Language Processing
Conditions: Oligoastrocytoma;   Astrocytoma;   Oligodendroglioma
Interventions: Device: fMRI;   Procedure: tractography;   Other: neuropsychological examination
10 Recruiting Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Conditions: Glioblastoma;   Anaplastic Astrocytoma;   Anaplastic Oligoastrocytoma;   Glioma;   Brain Neoplasm;   Brain Cancer;   Brain Tumor;   Brain Tumor, Recurrent;   Brain Neoplasm, Malignant
Interventions: Drug: Intra-arterial Cetuximab;   Drug: Intra-arterial Mannitol;   Radiation: Hypofractionated re-irradiation
11 Active, not recruiting FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
Conditions: Astrocytoma;   Oligoastrocytoma;   Oligodendroglioma
12 Completed HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas
Conditions: Astrocytoma;   Oligoastrocytoma;   Oligodendroglioma
Intervention: Biological: Peptide vaccine + Poly-ICLC
13 Unknown  A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas
Conditions: Astrocytoma;   Oligodendroglioma;   Oligoastrocytoma
Intervention: Drug: Temozolomide
14 Terminated Treatment Strategy for Low-grade Gliomas
Conditions: Astrocytomas;   Oligodendrogliomas;   Oligoastrocytoma
Interventions: Radiation: Radiation therapy;   Drug: Temozolomide
15 Completed Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
Conditions: Anaplastic Astrocytoma;   Oligodendroglioma;   Oligoastrocytoma
Interventions: Drug: Temozolomide;   Radiation: Focal radiotherapy
16 Recruiting A Study on β-elemene as Maintain Treatment for Complete Remission Patients of Newly Diagnosed Malignant Gliomas Following Standard Treatment
Conditions: Anaplastic Oligoastrocytoma;   Anaplastic Astrocytoma;   Glioblastoma
Intervention: Drug: β-elemene
17 Recruiting A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
Conditions: Anaplastic Oligoastrocytoma;   Anaplastic Astrocytoma;   Glioblastoma
Interventions: Drug: Temozolomide;   Drug: α-IFN
18 Not yet recruiting Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas
Conditions: Glioma;   Anaplastic Oligoastrocytoma;   Glioblastomas (GBM)
Interventions: Procedure: Structural Image Guidance;   Procedure: Metabolic Image Guidance
19 Withdrawn Re-irradiation of High Grade Gliomas: a Quality of Life Study
Conditions: Anaplastic Astrocytoma;   Glioblastoma Multiforme;   Anaplastic Oligoastrocytoma
Interventions: Other: EORTC QLQ-C30;   Other: EORTC QLQ-BN20;   Other: Hopkins Verbal Learning Test-Revised (HVLT-R);   Other: Stroop color-word test;   Other: Controlled oral word association test (COWA);   Other: Jamar hand dynamometer;   Other: EORTC QLQ- FA13;   Other: Trail Making Test (TMT)
20 Active, not recruiting Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma
Conditions: Central Nervous System Tumors;   Brain Tumor
Intervention: Drug: temozolomide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.